Skip to content
Homepage
Author:
TransMedics Group, Inc.
Posted Date:
February 10, 2026
TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
TransMedics Group, Inc.
February 10, 2026
TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial
TransMedics Group, Inc.
February 9, 2026
Prev
1
2
